PharmStockPharmacy Stock

Namenda
Namenda

0.55
A generic medicine indicated for neurological conditions. Regulates glutamate activity to protect brain cells from overstimulation and clarify cognitive communication pathways.
Ingredient
Memantine
Category
Neurology
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Memantine hydrochloride
Reference Brand
Memantine
Product Origin
Generic Alternative
Reference Manufacturer
Forest Laboratories
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
NMDA Receptor Antagonist
Pharmacological Class
Alzheimer's Disease Therapy
Manufacturer Description
Intended to relieve progressive cognitive decline to support memory retention and target central glutamate activity.
Mechanism of Action
Acts as an uncompetitive antagonist at NMDA glutamate receptors, blocking background excitotoxicity while permitting physiological signaling.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Severe hypersensitivity to memantine
Severe Adverse Events
Severe hypersensitivity anaphylaxis — requires immediate medical attention
Common Side Effects
Dizziness, Headache, Confusion
Uncommon Side Effects
Constipation, Somnolence, Hypertension
Drug Interactions
Amantadine, Acetazolamide
Pregnancy Safety Warnings
TGA Category B: Safety established in animal models. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Aricept, Donamem
Information related to Namenda is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Hay Fever Treatment - Buy Hydroxyzine Australia